A detailed history of Headlands Technologies LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 1,616 shares of VCYT stock, worth $45,005. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,616
Holding current value
$45,005
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$29.65 - $46.14 $47,914 - $74,562
1,616 New
1,616 $47,000
Q1 2023

May 01, 2023

BUY
$20.58 - $27.89 $452 - $613
22 New
22 $0

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.99B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.